151 related articles for article (PubMed ID: 25182645)
1. Nitrotriazole- and imidazole-based amides and sulfonamides as antitubercular agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Arena A; Arrieta F; Rebolledo JC; Smith DK
Antimicrob Agents Chemother; 2014 Nov; 58(11):6828-36. PubMed ID: 25182645
[TBL] [Abstract][Full Text] [Related]
2. The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Papadopoulou MV; Bloomer WD; Rosenzweig HS
Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106
[TBL] [Abstract][Full Text] [Related]
3. The antitrypanosomal and antitubercular activity of some nitro(triazole/imidazole)-based aromatic amines.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Kaiser M
Eur J Med Chem; 2017 Sep; 138():1106-1113. PubMed ID: 28763645
[TBL] [Abstract][Full Text] [Related]
4. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Kaiser M
Eur J Med Chem; 2014 Nov; 87():79-88. PubMed ID: 25240098
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.
Ashtekar DR; Costa-Perira R; Nagrajan K; Vishvanathan N; Bhatt AD; Rittel W
Antimicrob Agents Chemother; 1993 Feb; 37(2):183-6. PubMed ID: 8452346
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of 2-(2-isonicotinoylhydrazineylidene)propanamides as InhA inhibitors with high antitubercular activity.
Pflégr V; Horváth L; Stolaříková J; Pál A; Korduláková J; Bősze S; Vinšová J; Krátký M
Eur J Med Chem; 2021 Nov; 223():113668. PubMed ID: 34198149
[TBL] [Abstract][Full Text] [Related]
8. A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis
Patel N; O'Malley T; Zhang YK; Xia Y; Sunde B; Flint L; Korkegian A; Ioerger TR; Sacchettini J; Alley MRK; Parish T
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674058
[TBL] [Abstract][Full Text] [Related]
9. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
Khan A; Sarkar S; Sarkar D
Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Dusthackeer VNA; Rode HB
Eur J Med Chem; 2019 Feb; 164():665-677. PubMed ID: 30654238
[TBL] [Abstract][Full Text] [Related]
12. Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation.
Shalini ; Viljoen A; Kremer L; Kumar V
Bioorg Med Chem Lett; 2018 May; 28(8):1309-1312. PubMed ID: 29551480
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
Santivañez-Veliz M; Pérez-Silanes S; Torres E; Moreno-Viguri E
Bioorg Med Chem Lett; 2016 May; 26(9):2188-93. PubMed ID: 27025343
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of new N-(4-(4-chloro-1H-imidazol-1-yl)-3-methoxyphenyl)amide/sulfonamide derivatives as possible antimicrobial and antitubercular agents.
Ranjith PK; Pakkath R; Haridas KR; Kumari SN
Eur J Med Chem; 2014 Jan; 71():354-65. PubMed ID: 24361479
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation.
Kumar D; Beena ; Khare G; Kidwai S; Tyagi AK; Singh R; Rawat DS
Eur J Med Chem; 2014 Jun; 81():301-13. PubMed ID: 24852277
[TBL] [Abstract][Full Text] [Related]
16. Anti-Mycobacterial Activity of Tamoxifen Against Drug-Resistant and Intra-Macrophage Mycobacterium tuberculosis.
Jang WS; Kim S; Podder B; Jyoti MA; Nam KW; Lee BE; Song HY
J Microbiol Biotechnol; 2015 Jun; 25(6):946-50. PubMed ID: 25639719
[TBL] [Abstract][Full Text] [Related]
17. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
[TBL] [Abstract][Full Text] [Related]
18. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.
Krishna VS; Zheng S; Rekha EM; Nallangi R; Sai Prasad DV; George SE; Guddat LW; Sriram D
Eur J Med Chem; 2020 May; 193():112178. PubMed ID: 32171154
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
